VBI Vaccines Inc/BC Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2016 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
VBI Vaccines Inc/BC quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2016 to Q1 2024.
  • VBI Vaccines Inc/BC Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2024 was -$17.9M, a 35.5% increase year-over-year.
  • VBI Vaccines Inc/BC Net Income (Loss) Attributable to Parent for the twelve months ending March 31, 2024 was -$83M, a 30.7% increase year-over-year.
  • VBI Vaccines Inc/BC annual Net Income (Loss) Attributable to Parent for 2023 was -$92.8M, a 18.1% increase from 2022.
  • VBI Vaccines Inc/BC annual Net Income (Loss) Attributable to Parent for 2022 was -$113M, a 62.4% decline from 2021.
  • VBI Vaccines Inc/BC annual Net Income (Loss) Attributable to Parent for 2021 was -$69.8M, a 50.9% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$83M -$17.9M +$9.85M +35.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$92.8M -$13K +$21.1M +99.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-16
Q3 2023 -$114M -$20.4M +$4.77M +18.9% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 -$119M -$44.6M +$1.07M +2.34% Apr 1, 2023 Jun 30, 2023 10-Q 2023-11-14
Q1 2023 -$120M -$27.8M -$6.5M -30.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$113M -$21.1M -$2.36M -12.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-16
Q3 2022 -$111M -$25.2M -$9.36M -59.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$102M -$45.7M -$28.2M -161% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-14
Q1 2022 -$73.4M -$21.3M -$3.61M -20.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-14
Q4 2021 -$69.8M -$18.8M -$3.42M -22.3% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-13
Q3 2021 -$66.3M -$15.8M -$2.85M -21.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$63.5M -$17.5M -$7.96M -83.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-10
Q1 2021 -$55.5M -$17.6M -$9.29M -111% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-10
Q4 2020 -$46.2M -$15.4M -$4.49M -41.3% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-07
Q3 2020 -$41.7M -$13M +$3.17M +19.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 -$44.9M -$9.51M +$3.66M +27.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-08
Q1 2020 -$48.6M -$8.36M +$6.25M +42.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-08
Q4 2019 -$54.8M -$10.9M +$8.37M +43.5% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-02
Q3 2019 -$63.2M -$16.2M -$792K -5.15% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-02
Q2 2019 -$62.4M -$13.2M +$3.56M +21.3% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-31
Q1 2019 -$66M -$14.6M -$2.36M -19.2% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 -$63.6M -$19.2M -$7.71M -66.8% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-05
Q3 2018 -$55.9M -$15.4M -$5.57M -56.8% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 -$50.3M -$16.7M -$7.72M -85.6% Apr 1, 2018 Jun 30, 2018 10-Q 2019-11-06
Q1 2018 -$42.6M -$12.3M -$3.61M -41.8% Jan 1, 2018 Mar 31, 2018 10-Q 2019-11-06
Q4 2017 -$39M -$11.5M -$3.13M -37.2% Oct 1, 2017 Dec 31, 2017 10-K 2018-02-26
Q3 2017 -$35.9M -$9.8M -$2.5M -34.3% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 -$33.4M -$9.01M -$2.6M -40.5% Apr 1, 2017 Jun 30, 2017 10-Q 2018-07-26
Q1 2017 -$30.8M -$8.64M -$7.56M -701% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-01
Q4 2016 -$23.2M -$8.41M Oct 1, 2016 Dec 31, 2016 10-K 2018-02-26
Q3 2016 -$7.3M Jul 1, 2016 Sep 30, 2016 10-K 2018-02-26
Q2 2016 -$6.42M Apr 1, 2016 Jun 30, 2016 10-K 2018-02-26
Q1 2016 -$1.08M Jan 1, 2016 Mar 31, 2016 10-K 2018-02-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.